7-({Methanesulfonyl-[4-(piperidin-4-yloxy)-phenyl]-amino}-methyl)-naphthalene-2-carboxamidine | 772318-01-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 7-({Methanesulfonyl-[4-(piperidin-4-yloxy)-phenyl]-amino}-methyl)-naphthalene-2-carboxamidine
• CAS: 772318-01-1
• 化学式: C₂₄H₂₈N₄O₃S
• 分子量: 452.577
• InChiKey: ONLWUXIRZUCJSJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.22
• 重原子数：
  32.0
• 可旋转键数：
  7.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  108.51
• 氢给体数：
  3.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  乙基乙酰亚胺盐酸盐 、 7-({Methanesulfonyl-[4-(piperidin-4-yloxy)-phenyl]-amino}-methyl)-naphthalene-2-carboxamidine 在 三乙胺 作用下， 以 乙醇 为溶剂， 生成 N-{4-[(1-Acetimidoyl-4-piperidyl)oxy]phenyl}-N-[(7-amidino-2-naphthyl)methyl]methanesulfonamide
  参考文献：
  名称：

  Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors

  摘要：

  A series of benzoxazinone derivatives was designed and synthesized as factor Xa inhibitors. We demonstrated that the naphthyl moiety in the aniline-based compounds I and 2 can be replaced with benzene-fused heterobicycles and biaryls to give factor Xa inhibitors with improved trypsin selectivity. The P4 modifications lead to monoamidines which are moderately active. The benzoxazinones 41-45 are potent against factor Xa, retain the improved trypsin selectivity of the corresponding aniline-based compounds, and show strong antithrombotic effect dose responsively. (C) 2002 Published by Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(02)00927-7
• 作为产物：
  描述：

  N-{4-[(1-tert-butoxycarbonyl-4-piperidyl)oxy]phenyl}methanesulfonamide 在 羟胺 、 乙酸酐 、 caesium carbonate 、 溶剂黄146 、 三氟乙酸 作用下， 以 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 7-({Methanesulfonyl-[4-(piperidin-4-yloxy)-phenyl]-amino}-methyl)-naphthalene-2-carboxamidine
  参考文献：
  名称：

  Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors

  摘要：

  A series of benzoxazinone derivatives was designed and synthesized as factor Xa inhibitors. We demonstrated that the naphthyl moiety in the aniline-based compounds I and 2 can be replaced with benzene-fused heterobicycles and biaryls to give factor Xa inhibitors with improved trypsin selectivity. The P4 modifications lead to monoamidines which are moderately active. The benzoxazinones 41-45 are potent against factor Xa, retain the improved trypsin selectivity of the corresponding aniline-based compounds, and show strong antithrombotic effect dose responsively. (C) 2002 Published by Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(02)00927-7